Patent AT-E401071-T1: [Translated] USES AND COMPOSITIONS FOR SELECTIVE CANCER CHEMOTHERAPY

Description

A selective chemotherapy method includes the step of contacting tumor cells with a mineral ascorbate/vitamin C metabolite composition. A chemotherapeutic composition comprises the mineral ascorbate/vitamin C metabolite composition in a pharmacologically acceptable intravenous carrier.

Resources

Name Format Description Link
Official Data Source HTML Access the complete Patent AT-E401071-T1: [Translated] USES AND COMPOSITIONS FOR SELECTIVE CANCER CHEMOTHERAPY on the official website. Open resource

Tags

Topics

Categories